IL18 and Alzheimer disease: IL-18 stimulation of the neuron-like SH-SY5Y cell line increased expression of APP and APP processing enzymes such as BACE-1 and PS1 [37], further suggesting that IL-18 signaling may drive aspects of AD pathology.